Professor Helge Rasmussen divides his time between working as an interventional cardiologist and leading a team of researchers in molecular and cellular medicine. A particular focus of his research is learning how heart cells work, which has led to discoveries that could mean better treatment for heart failure and other forms of cardiovascular disease.
Your support powers our researchers to explore new medical breakthroughs in heart disease.
Professor Geoffrey Tofler has over 20 years’ experience as a clinical consultant cardiologist, including 13 years at Harvard Medical School Hospital in Boston.
Prof Gemma Figtree is committed to improving the care for heart attack patients, using her knowledge of redox signalling to develop methods of identifying those at highest risk of adverse outcomes, and discovering novel therapies, inspired by her clinical work as an interventional cardiologist at Royal North Shore Hospital.
Dr Belinda Di Bartolo is researching the two different risk factors in atherosclerosis – calcification and inflammation. She is looking to understand how calcium gets into the blood vessels, how it affects the blood vessels and why, when combined with inflammation, is it so damaging for the heart.
Dr Eveline Staub is a specialist in general paediatrics, neonatology and paediatric intensive care. Dr Staub is currently a consultant neonatologist at Royal North Shore Hospital, NSW, focusing on clinical work with patients and families, researching the development of kidneys after preterm birth and the long-term consequences on blood pressure and renal health.
Professor Ugander has a research interest in non-invasive cardiac imaging in general and cardiac magnetic resonance imaging (MRI) in particular, with a focus on the diagnoses ischemic heart disease, myocarditis, and heart failure, as well as basic cardiac pumping physiology.
Dr Gentile’s work focuses on cardiovascular regeneration and tissue engineering for heart attack. Dr Carmine’s current research involves working closely with cardiologists and cardiac surgeons to identify the best way to provide 3D bio-printed heart tissue for a patient who has suffered a heart attack.
Professor Kluckow is a Senior Staff Specialist in Neonatology at Royal North Shore Hospital in Sydney and a Professor of Neonatology at the University of Sydney, Australia. With his Sydney based research group, he has led the development of neonatal haemodynamics and point of care ultrasound in the neonatal unit for the past 23 years,
Dr Levi Bassin is a practicing cardiothoracic surgeon and is researching different ways to conduct coronary bypass surgery to reduce potential future graft failure and the need for subsequent therapy or surgery.
Dr Bonnitcha is a Chemical Pathology Registrar at RPA hospital and a Senior Clinical Lecturer at the Northern and Central Clinical Schools in the Medical Faculty.
Dr Anthony Ashton graduated with a PhD from UNSW and spent 12 years developing his skills in cardiovascular research at the Albert Einstein College of Medicine in New York. His research is focused on how abnormal reaction of maternal blood vessels can predispose a woman to life threatening complications during pregnancy.
Dr Allahwala has a keen interest in coronary artery disease, valvular heart disease, heart failure management and arrhythmias. He has a strong background in research having published more than 30 peer reviewed journal articles and book chapters.
As Laboratory Manager, Dr Tang is a key figure in the lab, sharing his knowledge and expertise with graduate students and medical researchers.
Dr Hamilton is directly responsible for performing many of the experiments that are conducted within Prof Rasmussen’s laboratory as well as providing a supervisory role to both students and research assistants within the lab.
Dr Roche, is a cardiac surgical trainee and has brought surgical skills and insights to the team supervised by Dr Gentile – a bioprinting expert who is working towards producing heart patches made of special ‘bio-ink’. Together, their project aims to regenerate parts of the heart that have died following a severe heart attack and help heart failure patients. The ‘bio-ink’ uses individualised stem cells taken from blood or skin samples which are then converted to beating heart cells.
Dr Di Wu is undertaking pre-clinical studies to try a new therapy to halt free radicals which alter the sodium pump and can cause scarring on the heart which can then lead to heart failure.